CHDM clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for

  • DMCRN-02-001: Assessing Pediatric Endpoints in DM1

    Sorry, not currently recruiting here

    The overall goal of the study is to establish valid clinical endpoint assessments for children with congenital myotonic dystrophy type 1 and childhood myotonic dystrophy type 1, and develop biomarkers for the condition.

    at UCLA

Our lead scientists for CHDM research studies include .

Last updated: